For example, the administration of monoclonal antibodies targeting α-chemokine interleukin-8 (also known as CXCL8 or IL-8) has demonstrated a significant reduction in clinical disease activity in cases of palmoplantar pustulosis [8]. The gene discussed is CXCL8; the disease is palmoplantar pustulosis.